IL6 and cancer: Oligo-Fucoidan can attenuate the negative effects of etoposide (ETO) chemotherapy that promotes IL-6 and MCP-1/CCL2 production in aggressive HCT116 cancer cells which activate Stat3 and Stat6 signaling [13], respectively.